Acute Lymphoblastic Leukemia (ALL)
What Is It?
Acute Lymphoblastic Leukemia (ALL) is a fast-growing cancer of the blood and bone marrow that affects white blood cells called lymphoblasts (immature lymphocytes). In ALL, the bone marrow produces a large number of abnormal lymphoblasts that crowd out healthy cells, impairing the body’s ability to fight infection, carry oxygen, and clot blood. It’s most common in children, but it can also affect adults.
Why It Matters
ALL is the most common childhood cancer, and it progresses quickly. If not treated promptly, it can be fatal within weeks or months. However, with early diagnosis and proper treatment, the prognosis—especially for children—can be very good. In adults, outcomes are more variable, but advancements in therapy continue to improve survival.
Key Facts (At a Glance)
Prevalence: About 6,500 new cases per year in the U.S.
Most Common In: Children under 5 (but can occur at any age)
Survival Rate: ~90% in children; ~35–45% in adults, depending on risk factors
Gender: Slightly more common in males than females
Race/Ethnicity: Higher rates in white and Hispanic populations in the U.S.
How It Affects the Body
ALL originates in the bone marrow, where it disrupts the production of healthy blood cells. Instead of maturing properly, lymphoblasts multiply uncontrollably, entering the bloodstream and potentially spreading to the lymph nodes, liver, spleen, and central nervous system. This leads to anemia, infections, and bleeding disorders due to the lack of healthy red cells, white cells, and platelets.
Common Symptoms
Fatigue and weakness (from anemia)
Frequent infections and fevers
Easy bruising or bleeding (e.g., nosebleeds, gum bleeding, petechiae)
Bone or joint pain
Swollen lymph nodes (especially in neck, underarms, or groin)
Loss of appetite and weight loss
Pale skin
Shortness of breath
Headaches or neurological symptoms if CNS is involved
Risks & Side Effects
If untreated, ALL can rapidly spread and become fatal. Potential complications include:
Central nervous system involvement
Sepsis (life-threatening infection)
Anemia-related heart strain
Severe bleeding
Treatment-related side effects (e.g., from chemotherapy or radiation), such as infertility, secondary cancers, and cognitive effects in children
Who Should Be Cautious
Risk factors for ALL include:
Previous cancer treatment (radiation or chemotherapy)
Genetic conditions like Down syndrome or Li-Fraumeni syndrome
Exposure to high radiation levels
Family history of leukemia (rare but possible)
ALL is not contagious and does not appear to have a strong environmental cause in most cases.
When to See a Doctor
Seek medical evaluation if you or a child experiences:
Persistent, unexplained fatigue or pallor
Frequent fevers or infections
Unusual bleeding or bruising
Bone pain or joint swelling
Swollen lymph nodes with no known infection
Early diagnosis and rapid treatment significantly improve outcomes.
Related Conditions / Interactions
Acute Myeloid Leukemia (AML): Another type of acute leukemia with different treatment
Chronic Lymphocytic Leukemia (CLL): A slower-growing form, usually in adults
Pancytopenia: A reduction of all blood cell types, common in advanced ALL
Tumor Lysis Syndrome: A treatment-related complication where rapid cell death causes metabolic imbalances
Last Updated: June 15, 2025

